2008-02-06 13:51 ET - News Release

Mr. Terrance Owen reports:

ALDA RECEIVES CHINESE PATENT

Vancouver, BC - ALDA Pharmaceuticals Corp. (APH:TSX-V, "ALDA") is pleased to announce that Chinese Patent Number ZL02829642.7 has been issued by the State Intellectual Property Office of the People's Republic of China. The patent provides protection for the composition and production methods for ALDA's T36(r) formulation until August 20, 2022.

Dr. Terrance Owen, President & CEO, states: "Receiving the Chinese patent is an important part of our intellectual property protection. There were very few modifications to the original patent application required by the Chinese patent office. This makes us very confident about the uniqueness of the technology and we feel that the patent adds credibility to the manufacturing and marketing rights that have been granted to ALDA's agent in China. We are continuing to work towards establishing a manufacturing facility in China in time for the Olympic Games that are taking place in Beijing this year. We are also excited and pleased by the issuance of the Chinese patent because it shows that we are able to deliver on the goals set out in our business plan."